Drawing for IMPEDE-XL MEGAFILL EMBOLIZATION PLUG

USPTO serial 99777976

IMPEDE-XL MEGAFILL EMBOLIZATION PLUG

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
HAYES, GINA CLARK
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IMPEDE-XL MEGAFILL EMBOLIZATION PLUG?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rebecca Y. McCurry

Rebecca Y. McCurry Pirkey Barber PLLC1801 East 6th Street, Suite 300Austin, TX 78702United States

Goods and services

ClassDescriptionStatusFirst use
010Medical and surgical apparatus and instruments for use in endovascular procedures; Medical apparatus for use in treating aneurysms, vascular disease, peripheral vascular embolization, varicoceles, pelvic congestion syndrome, gastric varices, traumatic hemorrhages, and neurovascular abnormalities; Surgical instruments for use in treating aneurysms, vascular disease, peripheral vascular embolization, varicoceles, pelvic congestion syndrome, gastric varices, traumatic hemorrhages, and neurovascular abnormalities; Medical apparatus for use in treating endovascular occlusion and vascular abnormalities; Surgical instruments for use in treating endovascular occlusion and vascular abnormalities; Medical and surgical apparatus and instruments for use in embolization procedures; Embolic devices for endovascular occlusion that conform to vessel walls and promote clot formation in neurovascular and peripheral vascular structures; Embolic devices for treating aneurysms comprised of embolization coils and polymer foam; Medical apparatus and instruments for use in surgeryACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 11, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 16, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 15, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 15, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 15, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 31, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 31, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 31, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 26, 2026DOCKASSIGNED TO EXAMINER—
Aug 25, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 21, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 21, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance